Amit Srivastava joins Legacy Healthcare India as Board Member

November 18, 2020 Pharma

Srivastava will head Legacy Healthcare’s India operations and lead the company’s initiatives from the India office in Bengaluru, with a focus on research to explore the diverse botanical resources that India has to offer to build the next botanical drugs, according to a statement.
Nutrify India Chief Catalyst Amit Srivastava has joined Legacy Healthcare India as Board Member and Director – India Operations.
Srivastava will head Legacy Healthcare’s India operations and lead the company’s initiatives from the India office in Bengaluru, with a focus on research to explore the diverse botanical resources that India has to offer to build the next botanical drugs, according to a statement.
Legacy Healthcare is a biopharma company headquartered at Lausanne in Switzerland. It is a pioneer in the development of drugs for the treatment of autoimmune and inflammatory diseases. It has a presence in the US, Japan and France and now in India at Bengaluru.
Saad Harti, Director and CEO, Legacy Healthcare, said, “We have been working with Nutrify India and now officially having Amit on board is an exciting opportunity for our company to explore botanics further.”
Amit Srivastava, Board Member, Legacy Healthcare India, said, “I am extremely happy to be associated with Legacy Healthcare. Their scope and mission of work is in absolute synchronicity with my passion for botanical-based healthcare development.”
Srivastava is currently also at the helm of affairs with Bengaluru-based Nutrify India, an idea-to-commercialisation platform that helps innovators connect with companies with larger market access or investors wishing to invest in innovative nutrition startups.
Nutrify India actively engages with biotech, medical devices and AI startups to deliver effective health outcomes from nutraceuticals.
Amit Srivastava is considered as a thought leader and a visionary in the Indian Nutraceutical industry. He recently launched the HI BHARAT (Health Ingredients Bio-Harmonized Applications in Rejuvenation and Therapeutics) project under which he has brought innovators, industry leaders and research labs together to deliver high-tech well-documented clinically-tested ingredients and formulations.

Source : economictimes.indiatimes

About the author

Gubba Group: